Reliable identification of brain cell types is necessary for studying brain cell 13 biology. Many brain cell marker genes have been proposed, but their reliability 14 has not been fully validated. We evaluated 540 commonly-used marker genes 15 of astrocyte, microglia, neuron, and oligodendrocyte with six transcriptome and 16 proteome datasets from purified human and mouse brain cells (n=125). By 17 setting new criteria of cell-specific fold change, we identified 22 gold standard 18 marker genes (GSM) with stable cell-specific expression. Our results call into 19 question the specificity of many proposed marker genes. We used two single-20 cell transcriptome datasets from human and mouse brains to explore the co-21 expression of marker genes (n=3337). The mouse co-expression modules were 22 perfectly preserved in human transcriptome, but the reverse was not. Also, we 23 proposed new criteria for identifying marker genes based on both differential 24 expression and co-expression data. We identified 16 novel candidate marker 25 genes (NCM) for mouse and 18 for human independently, which have the 26 potential for use in cell sorting or other tagging techniques. We validated the 27 specificity of GSM and NCM by in-silico deconvolution analysis. Our systematic 28 evaluation provides a list of credible marker genes to facilitate correct cell 29 identification, cell labeling, and cell function studies. 30 31 development of marker genes, which are sets of genes that express specifically 41 in a cell type. Thousands of genes have been proposed as marker genes 2 . One 42 well-known marker gene, RBFOX3 (gene of NeuN), is only expressed in nuclei 43 of most neuronal cell types 3 . Marker genes can be used in several applications.
Introduction 32
The human brain is a heterogeneous organ with numerous cell types. It has 33 billions of cells including half neurons and half glia 1 . The major classes of glia 34 are astrocyte, microglia and oligodendrocyte. Identifying these cell types is 35 important because it would permit the brain to be understood in greater detail 36 and would be especially useful for studying cellular contributions to the 37 psychiatric disorders. A critical need in neuroscience research, is to develop 38 methods to reliably identify specific brain cell types. 39 A strategy that has been employed to identify specific cell types is the 40 72 BCCM marker genes were higher than those of the 35 non-BCCM marker 172 genes in all six DGEDats ( Figure 3A , p-value of two-sample Wilcoxon test 173 <0.05). In other words, marker genes in the BCCMs were more specific than 174 the marker genes in the non-BCCMs. Significantly higher csFC values of 175 marker genes in BCCMs than in non-BCCMs were also observed in mouse 176 data ( Supplementary Figure 5A , p-value of two-sample Wilcoxon test <0.05).
177
This suggests that the highly-specific marker genes are more likely to be placed 178 in a BCCM. 179 Based on the test above, we next hypothesized that the highly-specific 180 marker genes positioned close to the hub of the BCCMs have module 181 membership rankings that are higher than non-GSM in the same BCCM. We 182 divided the 72 marker genes in the human BCCMs into 20 GSM as identified 183 above and 52 non-GSM. To compare the module membership ranking of these 184 two gene groups, we performed a two-sample Wilcoxon test on their module 185 membership (kME). kME is a measurement parameter used to assess the 186 correlation between a gene and the eigengene, the hub of the co-expression 187 module. A gene with high kME means that it has high correlations with other 188 genes and consequently high ranking in the module. The kME values of GSM 189 were significantly higher than those of non-GSM in the human BCCMs (p-value 190 of two-sample Wilcoxon test<0.05, Figure 3B ). However, the ranking of GSM in 191 the BCCMs was not significantly higher than non-GSM in the mouse data (p-192 value of two-sample Wilcoxon test = 0.13, Supplementary Figure 5B ). 193 These two analyses suggested that a connection did exist between DGE and 194 COE for the marker genes. We further chose csFC representing DGE, and kME 195 representing COE, to study the relationship between them. Significant 196 correlations were observed between csFC values from five of the six DGEDats 197 and kME values from human co-expression network (Spearman rho>0.2, p < 198 0.05; Figure 3C ). In the mouse data, kME values of the marker genes were (Table 4 , Supplementary Table S4 ). Because only one DGEDat for 214 the human brain was available for analysis, we set relatively stricter criteria for 215 human NCM to make more conservative calls. The human NCM should have 216 1) csFC significantly larger than 4 in the DGEDat1 (BH corrected p-value < 0.05) 217 and 2) kME should be greater than 0.8 in the COEDat1. We identified 18 human 218 NCM meeting these criteria (Table 4 , Supplementary Table S5 ).
220
GSM and NCM improve the performance of supervised deconvolution 221 We used supervised deconvolution to examine how the choice of marker 222 genes impacts deconvolution results using mouse data. We hypothesized that 223 including GSM and NCM would improve deconvolution accuracy compared to 224 not having them in the calculations. We downloaded mouse expression data 225 from purified neuron, astrocyte, oligodendrocyte, and microglia, as well as RNA 226 mixtures with known proportions of each cell type 31 . The purified cell expression 227 data was used as a reference profile, and the mixture data was used for 228 deconvolution. We constructed four types of reference gene sets: baseline,
229
GSM_plus, NCM_plus, and NCM_GSM_plus. The baseline reference gene set 230 included all the genes except for GSM and NCM. The other references were 231 constructed by adding GSM, NCM, and their combination into the baseline 232 reference. We used the root mean square error (RMSE) between estimated cell 233 proportions and the true proportion to evaluate deconvolution performance.
234
Higher RMSE indicated poorer performance of deconvolution. The optimal 235 number of marker genes for deconvolution was determined (Materials and 236 Methods). We found that the deconvolutions with baseline reference of 400 237 genes had the lowest RMSE, so we used this number of genes to construct the 238 four tested references. 239 We observed that adding either set of GSM or NCM into the reference 240 reduced the RMSE (Figure 4 ), suggesting that the inclusion of GSM and NCM 241 can improve the performance of deconvolution. The reference including both 242 NCM and GSM performed the best. To prove that the improved performance of 243 the reference with NCM or GSM was not because of a larger number of marker 244 genes used, we completed permutations by constructing three permutated 245 references with randomly selected genes, excluding GSM and NCM. The 246 permutation was repeated 1000 times for each type of permutated reference.
247
Deconvolution using a reference with GSM or NCM outperformed the 248 deconvolution using a permutated reference without GSM or NCM, showing 249 that improved deconvolution performance when GSM and NCM were included 250 was not related to the increased reference size ( Figure 4B ). The current study describes the first systematic evaluation of marker gene 254 specificity and their reliability for identifying cell types in human and mouse 255 brains. We not only evaluated the published marker genes but also designed 256 new criteria to discover novel marker genes based on both differential gene 257 expression and co-expression. Applying our proposed novel marker genes to 258 deconvolution improved the performance of deconvolution and resulted in more 259 accurate cell proportion estimates.
260
This study identified a set of marker genes to discriminate neurons, 261 astrocytes, microglia, and oligodendrocytes. New brain cell types have recently 262 been identified with the development of single-cell RNA sequencing 32 . The 263 evaluation of marker genes for these new cell types cannot be achieved 264 currently because the multi-omics for these new cell types are not available. 265 We required the cell types in evaluation to be measured at both transcriptome 266 and proteome level, and currently only the four major cell types above satisfied 267 the criteria. Our method will be adaptable to the newly identified brain cell types 268 when multi-omics data are available.
269
One of the important outcomes of the current study was validating the Figure 1) . Some genes that we tested (27 / 274 540) had conflict definitions for different cell types including several well-known 275 marker genes, such as GFAP 33 and ITGAM 34 . Our evaluation refined a list of 276 reliable marker genes and supported using GFAP as a marker of astrocytes 277 and ITGAM as a marker of microglia. 278 We were strict in assessing the specificity of marker genes, which led to 279 removing some genes from commonly used marker gene lists. We compared 280 the classic fold-change and cell type-specific fold-change of consistent marker 281 genes ( Supplementary Table 2 ). Eight marker genes were imprecisely defined 282 in more than three of six DGEDats using the classic fold change. For example,
283
SELENBP1 was a claimed astrocyte marker gene using averaged ranks across 284 comparisons with each of other cell types 13 . However, its expression in 285 microglia is close to, or even higher than expression in astrocytes in DGEDat2-286 DGEDat6. We removed it from the marker gene list because of its similar 287 expression in microglia and astrocyte (Supplementary Figure 2 ). Most of the 288 candidate marker genes failed to meet our criteria of GSM due to either being 289 expressed at a similar level in more than two cell types (17%) or not being 290 detectable as protein in the target cell type (20%), such as RBFOX3 and 291 TMEM119. These two genes both showed target cell specificity when they 292 could be detected ( Supplementary Table 6 ). We expect that more marker genes 293 including these two genes may be reclassified as GSM when more reliable 294 proteomics data becomes available. 295 We showed a positive correlation between the csFC and kME of marker 296 genes in both human and mouse brain. This is in line with our expectation that 297 good marker genes will have similar expression patterns across cell types and 298 strongly correlate with each other, which forms the core part of the cell module.
299
The most important meaning of the strong correlation is that it suggests COE 300 can be used for discovering marker genes. COE used all cell types, both 301 characterized and uncharacterized, in brain tissue while DGE only used the 302 several measured cell types to identify marker genes. The marker genes 303 identified by COE should be more robust because they showed cell type-304 specificity across a broader range of cell types. This relationship will help to 305 identify more brain cell marker genes from single-cell sequencing data, a 306 technique that is increasing in popularity.
307
To explore the potential use of antibodies of NCM for cell labeling, we 308 checked NCM's subcellular localization of expression in the COMPARTMENTS 309 database 35 and the Allen Brain Atlas 36 . Eight human NCM and six mouse NCM 310 are expressed on the plasma membrane, suggesting that antibodies made to 311 these gene products have potential for use in FACS. One human NCM and 312 seven mouse NCM are expressed at the nucleus, suggesting their potential use 313 in sorting nuclei. Most of the mouse NCM already had archive ISH data except 314 Elavl4. However, for the human brain, only SNTA1 had ISH data in the database. we identified improved the performance of deconvolution slightly (0.3%) and is 328 less resource intensive.
329
To date, various studies have found similarities and differences between 330 tissue of humans and mice at the transcriptome level 17, [38] [39] [40] . A study found a 331 high degree of co-expression module preservation between human and mouse 332 brain, and all mouse modules showed preservation with at least one human 333 module whereas there were multiple human-specific modules 41 . The modules 334 enriched in neuronal markers were more preserved between species than 335 modules enriched glial marker genes 41 . This work conducted at the tissue level 336 is consistent with our results showing that mouse shared BCCMs with human, 337 but the BCCMs of the human brain were human-specific, except the neuron- differences between human and rodent were cell type-specific 42 . Our data add 341 to accumulating evidence that human have more cell-specific co-expression 342 modules than mouse. Importantly, this implies that research on brain-related 343 diseases using mouse models may have limited applicability to humans 344 because of the difference between human and mouse brain cells. Furthermore, 345 the definitions of brain cell types should consider species differences.
346
Our work is limited by the lack of cell-specific gene expression data with a 347 large sample size and replication. This made the criteria for the evaluation less 348 universal and more specific to our data sets. We could only calculate the p-349 value for four of six DGEDats due to lack of replication. Another limitation is the 350 data used in the discovery of the relationship between DGE and COE were not 351 from the same samples. This may explain why we did not observe strong 352 correlations in all tested datasets.
353
Through a comprehensive evaluation of the brain cell marker genes; we 354 developed a new method to identify marker genes, and provide a list of reliable 355 marker genes for brain cells to guide the cell identification. Recently, studies 356 reported methylome 43 and regulome 44 of brain cells, creating the potential to 357 develop marker genes at epigenetics level. It would be meaningful to construct 358 a framework by combining different omics data and methods to fully describe 359 the cell types in the brain.
361

Materials and Methods
362
DGEdats pre-processing and quality control 363 We collected six datasets for the DGE-based evaluation. 1) DGEDat1 15 : Cells 364 were isolated from the human temporal lobe cortex by immunopanning. We platform. We downloaded the raw CEL file. All the CEL files were subjected 374 together to background correction, normalization and summary value 375 calculation using the R package affy 45 ('rma' function). The probes with 'A' or 376 'M' state in more than two samples were removed. 4) DGEDat4 11 : Cells were 377 isolated from E16.5 and P1 mouse brain to culture neuron and glia cells. We counts. We downloaded the counts matrix.
400
COEDats were pre-processed in Automated Single-cell Analysis Pipeline 401 (ASAP) 48 . Genes with Counts per Million (CPM) lower than 1 in more than ten 402 samples were removed from human brain data, and genes with CPM lower than 403 1 in more than 50 samples were removed from mouse brain data. After quality 404 control, 13941 and 12149 genes were retained for human and mouse brain, 405 respectively. The human brain data were normalized by voom function. Mouse 406 data was normalized by scLVM. In total, 57 ERCC spike-ins in mouse data were 407 used for fitting of technical noise. The normalized data were retained.
409
Deconvolution data pre-processing and quality control 410 Gene expression data of brain samples with known cell proportion from rat 411 was used in cell type-specific deconvolution 31 (GEO accession: GSE19380).
412
This dataset contains four different cell types including neuron, astrocyte 413 oligodendrocyte and microglia, and two replicates of five different mixing 414 proportions ( Supplementary Table 7 ). The platform used was Affymetrix Rat 415 Genome 230 2.0 Array. All the CEL files were subjected together to background 416 correction, normalization and summary value calculation using 'rma' function.
418
Co-expression analysis 419 To determine the gene networks of specific cell types, we completed Supervised deconvolution 443 We used function 'lsfit' in CellMix 4 for deconvolution. In each mixture sample, was solved for X with the R function 'lsfit' (linear least squares algorithm).
458
The change of reference size was achieved by the following steps: 1)
459
Construct the marker gene pool for four cell types and calculate the csFC. 2) 460 Sort the marker gene pool according to the csFC in descending order. 3)
461
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